Lomerizine Dihydrochloride is primarily used as a calcium channel blocker, specifically targeting the brain’s blood vessels. It is effective in the treatment of migraines, particularly in reducing the frequency and severity of attacks. By improving cerebral blood flow and reducing vascular spasms, it helps alleviate symptoms associated with migraines and other cerebrovascular disorders. Additionally, it has shown potential in managing vertigo and dizziness by stabilizing blood flow in the inner ear. Its neuroprotective properties are also being explored for potential use in conditions like stroke and neurodegenerative diseases.